Asia
Takeda Pharmaceutical released data from its Phase IIIb/IV clinical trial for Adynovate. On the same day, jurors in a Delaware federal court ordered Takeda’s Baxalta unit to pay $155.19 million to Bayer AG for infringing a patent for Adynovate.
Suven Life Sciences Limited announced its Un-audited financial results for the quarter ended 31st December 2018.
China represents the largest market for baby food globally
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that Teijin’s board of directors has elected Ichiro Watanabe, currently corporate officer of the Teijin Group, as its next president.
Eisai Co. and Purdue Pharma presented data at the Sleep Research Society’s Conference regarding their lemborexant for the treatment of insomnia. The meeting was held in Clearwater Beach, Florida.
Leading provider of premium medical devices and hygiene products successfully launchesSuprasorb® CNP P3 and Debrisoft Pad for the first time in the region
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
In November, Chinese researcher He Jiankui of the Southern University of Science and Technology of China announced he had used CRISPR to alter the embryos of seven couples to make them resistant to HIV. To date, a set of twins were born and there is another pregnancy. This was met by near-universal condemnation in the global scientific community.
It’s no secret that the global biopharma and life sciences industry is large. Sometimes the immense size of the industry can lead fascinating news tidbits to fall through the cracks, particularly those from smaller companies scattered across the globe. This week BioSpace will launch a new roundup of news from companies across the globe.
Accelerated Evolution Biotechnologies(AEBi)’s claims to have found a cure for cancer are, appropriately, being met with global skepticism. Learn more about it here.
PRESS RELEASES